Related Experiment Videos
Meningeal myeloma
American Journal of Clinical Pathology
|October 1, 1982
Abstract:
A case of leptomeningeal myeloma is described and a brief review of the reported cases is made. Afflicted patients may be neurologically asymptomatic or may present with a clinical picture similar to carcinomatous and lymphomatous meningitis. Atypical plasma cells and monoclonal immunoglobulin in the cerebrospinal fluid (CSF) are the two most important findings for the diagnosis of leptomeningeal involvement in a patient with multiple myeloma.
Insights
Leptomeningeal myeloma, a rare complication of multiple myeloma, can present with varied neurological symptoms. Diagnosis relies on identifying atypical plasma cells and monoclonal immunoglobulin in cerebrospinal fluid (CSF).
Area of Science:
- Neurology
- Oncology
- Hematology
Background:
- Multiple myeloma is a plasma cell malignancy.
- Leptomeningeal myeloma involves cancer spread to the brain and spinal cord linings.
- This condition is rare but can significantly impact patient prognosis.
Observation:
- Patients may exhibit no neurological symptoms or mimic carcinomatous/lymphomatous meningitis.
- A case of leptomeningeal myeloma is presented.
- A review of previously reported cases is included.
Findings:
- Atypical plasma cells in cerebrospinal fluid (CSF) are a key diagnostic marker.
- Monoclonal immunoglobulin detected in CSF is crucial for diagnosis.
- These findings aid in identifying leptomeningeal involvement.
Implications:
- Early diagnosis of leptomeningeal myeloma is vital for timely intervention.
- Understanding diagnostic markers improves patient management.
- Further research into this rare complication is warranted.